WHO resumes using hydroxychloroquine in trials

After a weeklong review of safety data, the World Health Organization announced today that it’s ending a “pause” in the use of the antimalarial drug hydroxychloroquine in an international clinical trial of potential COVID-19 therapies.

Get the news brief on GeekWire.

By Alan Boyle

Mastermind of Cosmic Log, contributor to GeekWire and Universe Today, author of "The Case for Pluto: How a Little Planet Made a Big Difference," past president of the Council for the Advancement of Science Writing.

Leave a Reply

%d bloggers like this: